Thin-Shelled PEGylated Perfluorooctyl Bromide Nanocapsules for Tumor-Targeted Ultrasound Contrast Agent

Figure 7

MDA-MB-231 cell uptake study of (a) cetuximab-labeled NCm100 and (b) nonlabeled NCm100 for specific targeting evaluation. Blue: nuclei (DAPI); red: cetuximab-labeled NCm100 or nonlabeled NCm100 (Nile Red).